✨ Wrap-up of the 2025 Science Festival at INEM! ✨

On Saturday, October 4, the Necker Institute for Sick Children opened its doors to the public and turned into a space for exchanges and discoveries between researchers and visitors.
Thanks to the energy and commitment of our volunteers, more than 140 curious minds of all ages were able to explore research through interactive workshops.

On October 9 and 10, INEM welcomed school groups:

Researchers from the Membramics Lab, in collaboration with teams at Institut Pasteur and the Institute of Psychiatry and Neuroscience of Paris, have uncovered a novel mechanism by which Influenza A virus (IAV) manipulates host cell membranes to ensure the export of its genome.

Congratulations to Juliane da Graça, former PhD student in the Membramics Lab, and co-authors on their new study published in Cell Reports.

The paper sheds light on how interactions between the endoplasmic reticulum (ER) and endosomes contribute to the early stages of autophagy. The authors show that during nutrient stress, these organelle contact sites form specialized environments that support the initiation of phagophore formation, the first step in autophagosome biogenesis.

Key findings:

We are pleased to share that Juliane Da Graça, former PhD student at INEM under the supervision of Etienne Morel, has been awarded the prestigious 2025 Beth Levine Thesis Prize, which recognizes outstanding doctoral research in the field of autophagy.

We are proud to announce that Guillaume Canaud, head of the Translational Medicine and Targeted Therapies team and physician at the Necker Enfants Malades Hospital, is among the 15 recipients of the latest round of Chairs of Excellence in Biology/Health awarded as part of the France 2030 initiative, an ambitious program aimed at enhancing the attractiveness of French biomedical research.

We are pleased to share that Nicolas Venteclef’s team, Immunity and Metabolism of Diabetes (IMMEDIAB), has been awarded the prestigious FRM team label, a mark of scientific excellence from the Fondation pour la Recherche Médicale, in recognition of the project’s high scientific value and potential impact on metabolic disease research.

We are pleased to share that Fabiola Terzi’s team, Mechanisms and Therapeutic Strategies of Chronic Kidney Disease, has been awarded the prestigious FRM team label, a mark of scientific excellence from the Fondation pour la Recherche Médicale.

This recognition will support their research on chronic kidney disease (CKD), a condition that affects approximately 10% of the global adult population and may lead to end-stage renal failure requiring dialysis or transplantation.